By: Quiver InsiderRadar, Automated

Posted: 17 hours ago / Aug. 21, 2026 10:31 p.m. UTC

Peter George Colis, the CEO and Secretary of $LIFE, sold 24,564 shares of the company on 08-21-2026 for an estimated $817,981. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.6% of their shares of this class of stock. Following this trade, they now own 1,541,396 shares of this class of $LIFE stock.

$LIFE Insider Trading Activity

LIFE Insider Trades

$LIFE insiders have traded $LIFE stock on the open market 60 times in the past 6 months. Of those trades, 0 have been purchases and 60 have been sales.

Here’s a breakdown of recent trading of $LIFE stock by insiders over the last 6 months:

  • 2019 GP, L.L.C. GV has made 0 purchases and 15 sales selling 754,824 shares for an estimated $15,125,689.
  • US (TTGP), LTD. SC has made 0 purchases and 16 sales selling 285,232 shares for an estimated $9,426,463.
  • LINGKE WANG (President) has made 0 purchases and 7 sales selling 187,305 shares for an estimated $5,739,918.
  • PETER GEORGE COLIS (CEO and Secretary) has made 0 purchases and 10 sales selling 173,825 shares for an estimated $5,123,503.
  • BRANDT WALTER KUCHARSKI (Chief Accounting Officer) has made 0 purchases and 8 sales selling 97,605 shares for an estimated $3,308,891.
  • CHRISTOPHER M. CAPOZZI (Chief Financial Officer) has made 0 purchases and 4 sales selling 106,770 shares for an estimated $2,677,572.

To track insider transactions, check out Quiver Quantitative’s insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

See also  Should You Read Anything Into AppFolio's CFO Parting With Stock? Here's What to Know

$LIFE Hedge Fund Activity

We have seen 37 institutional investors add shares of $LIFE stock to their portfolio, and 37 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds’ stock portfolios, check out Quiver Quantitative’s institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$LIFE Analyst Ratings

Wall Street analysts have issued reports on $LIFE in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Citizens issued a “Market Outperform” rating on 02/23/2026
  • Goldman Sachs issued a “Buy” rating on 02/23/2026
  • Baird issued a “Outperform” rating on 02/23/2026
  • B of A Securities issued a “Buy” rating on 02/23/2026
  • William Blair issued a “Outperform” rating on 02/23/2026
See also  Celanese CFO Chuck Kyrish Buys 2,300 Shares for $105,000. What Is This Telling Investors?

To track analyst ratings and price targets for $LIFE, check out Quiver Quantitative’s $LIFE forecast page.

$LIFE Price Targets

Multiple analysts have issued price targets for $LIFE recently. We have seen 9 analysts offer price targets for $LIFE in the last 6 months, with a median target of $21.0.

Here are some recent targets:

  • Ross Sandler from Barclays set a target price of $27.0 on 05/08/2026
  • Matthew J. Carletti from Citizens set a target price of $27.0 on 05/07/2026
  • Ronald Josey from Citigroup set a target price of $16.0 on 02/26/2026
  • Lee Horowitz from Deutsche Bank set a target price of $23.0 on 02/24/2026
  • Eric Sheridan from Goldman Sachs set a target price of $33.0 on 02/23/2026
  • Colin Sebastian from Baird set a target price of $18.0 on 02/23/2026
  • Michael McGovern from B of A Securities set a target price of $15.0 on 02/23/2026

This article is not financial advice. See Quiver Quantitative’s disclaimers for more information.


Source link